2489675-56-9

VSA 2 Chemical Structure
2489675-56-9

Chemical Structure

VSA 2

  • CAS No.: 2489675-56-9
  • Formula:C94H147NO42
  • Molecular Weight:1963.15

IUPAC Name: (2S,3R,4S,5R,6R)-3-(((2S,3R,4S,5S,6S)-4-(((2S,3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxy-6-methyl-5-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl (4aR,5R,6aS,6bR,8aR,9S,10S,12aR,12bR,14bS)-10-(((2R,3R,4S,5S,6S)-6-((11-(benzyloxy)-11-oxoundecyl)carbamoyl)-5-hydroxy-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-9-formyl-5-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate

InChIKey: WFMCHDRTLFYUIJ-MSZPQEBTSA-N

SMILES: O[C@H]([C@@H]([C@H]([C@@H](O1)C)O[C@H]2[C@@H]([C@H]([C@@H](CO2)O)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H](CO4)O)O)O)O)[C@@H]1O[C@H]([C@H]([C@H]([C@H](O5)C)O)O)[C@@H]5OC([C@]67[C@](CC(C)(CC7)C)([H])C8=CC[C@@]([C@@]9([C@@]([C@@](C)([C@H](CC9)O[C@H]%10[C@@H]([C@H]([C@@H]([C@H](O%10)C(NCCCCCCCCCCC(OCC%11=CC=CC=C%11)=O)=O)O)O[C@H]%12[C@@H]([C@@H]([C@H]([C@@H](O%12)C)O)O)O)O[C@@H]%13O[C@@H]([C@@H]([C@@H]([C@H]%13O)O)O)CO)C=O)([H])CC%14)C)([H])[C@]%14(C)[C@@]8(C[C@H]6O)C)=O

Biological Activity: VSA 2, a saponin-based vaccine adjuvant, is a derivative of Momordica saponin (MS) II. VSA 2 is an immunostimulant, shows consistent enhancement of immunoglobulin G2a (IgG2a) production when it was in formulation with either ovalbumin or recombinant hemagglutinin B (rHagB) antigen[1].

Cat. No. Product Name Purity Description Pricing
HY-N15770
VSA 2 VSA 2, a saponin-based vaccine adjuvant, is a derivative of Momordica saponin (MS) II. VSA 2 is an immunostimulant, shows consistent enhancement of immunoglobulin G2a (IgG2a) production when it was in formulation with either ovalbumin or recombinant hemagglutinin B (rHagB) antigen.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

Pricing 
Expand Hide
References